StartupEleven
Contact us
Vevo Therapeutics · San Francisco, CA, United States

Vevo Therapeutics

$12M$12M roundStartup profile

Fundamentalsi

Latest valuationNot disclosed
Credibility rating5/5
Revenue / run rateNot disclosed
StageStartup profile
Latest roundSeed · $12M
Total funding$12M
Team sizeTeam size not disclosed
LocationSan Francisco, CA, United States
IndustryArtificial Intelligence
Source records2

Ownership data

Cap table not disclosed

Vevo Therapeutics does not include shareholding history in the normalized startup source files.

Financial performance

All Financials
Source snapshot
REVENUE (USD)Not disclosed Not disclosed
FUNDING (USD)$12M Seed · $12M
Insufficient history

Historical revenue and profit series are not present in the source files for this private company.

REVENUE GROWTHVALUE

1Y (TTM)Not disclosed

3Y CAGRNot disclosed

PROFIT GROWTHVALUE

1Y (TTM)Not disclosed

3Y CAGRNot disclosed

About

Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.

This profile is normalized from the startup source files. Exact historical financials are shown only when present in the dataset.

CEO/MDon Curing Disease withFounded in2022StatusStartup profile

Sources

Angel Investors and Venture Capital (1)

InvestorTypeSignal
Founder / employee ownershipBootstrappedNot disclosed in source records

Similar companies

See more